345 related articles for article (PubMed ID: 28632145)
1. What really is an indeterminate FNA thyroid nodule?
Pezzolla A; Lattarulo S; Madaro A; Docimo G; Lacalendola E; Prete F; Marzaioli R
Ann Ital Chir; 2017; 88():275-281. PubMed ID: 28632145
[TBL] [Abstract][Full Text] [Related]
2. Correlation between cytological and histological findings in patients who underwent thyroidectomy. Predictive value and confounders.
Del Rio P; Cozzani F; Corcione L; Viani L; Loderer T; Rossini M
Minerva Endocrinol; 2019 Dec; 44(4):357-362. PubMed ID: 30256073
[TBL] [Abstract][Full Text] [Related]
3. Nondiagnostic thyroid fine needle aspiration cytology: outcome in surgical treatment.
Tamez-Pérez HE; Gutiérrez-Hermosillo H; Forsbach-Sánchez G; Gómez-de Ossio MD; González-González G; Guzmán-López S; Tamez-Peña AL; Mora-Torres NE; González-Murillo EA
Rev Invest Clin; 2007; 59(3):180-3. PubMed ID: 17910409
[TBL] [Abstract][Full Text] [Related]
4. Incidental thyroid carcinoma in patients with TIR1, TIR2 and TIR3 FNA.
Pezzolla A; Lattarulo S; Barile G; Paradies D; Pentassuglia G; Prete F; Marzaioli R
Ann Ital Chir; 2018; 89():113-117. PubMed ID: 29424371
[TBL] [Abstract][Full Text] [Related]
5. Role of cytological and ultrasonographic features in predicting the risk of malignancy in thyroid nodules with indeterminate cytology.
Saiegh L; Shechner C; Dickstein G; Sheikh-Ahmad M; Reut M; Odeh M; Toubi A; Bejar J
Minerva Endocrinol; 2014 Mar; 39(1):43-52. PubMed ID: 24513603
[TBL] [Abstract][Full Text] [Related]
6. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
7. Incidence of malignancy in thyroid nodules determined to be follicular lesions of undetermined significance on fine-needle aspiration.
Teixeira GV; Chikota H; Teixeira T; Manfro G; Pai SI; Tufano RP
World J Surg; 2012 Jan; 36(1):69-74. PubMed ID: 22057754
[TBL] [Abstract][Full Text] [Related]
8. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
9. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?
Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ
J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137
[TBL] [Abstract][Full Text] [Related]
10. Risk of malignancy in thyroid nodules with atipia of undetermined significance.
López Vázquez Y; Penín Álvarez M; San Miguel Fraile P; Barragáns Pérez M
Endocrinol Nutr; 2015 Dec; 62(10):507-10. PubMed ID: 26526719
[TBL] [Abstract][Full Text] [Related]
11. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].
Miseikyte-Kaubriene E; Ulys A; Trakymas M
Medicina (Kaunas); 2008; 44(3):189-94. PubMed ID: 18413985
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.
Williams MD; Suliburk JW; Staerkel GA; Busaidy NL; Clayman GL; Evans DB; Perrier ND
Ann Surg Oncol; 2009 Nov; 16(11):3146-53. PubMed ID: 19727961
[TBL] [Abstract][Full Text] [Related]
13. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
[TBL] [Abstract][Full Text] [Related]
14. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
15. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of BRAFV600E and RET/PTC oncogenes in thyroid nodule aspirates].
Guerra A; Carrano M; Angrisani E; Vitale M
Recenti Prog Med; 2013; 104(7-8):415-9. PubMed ID: 24042420
[TBL] [Abstract][Full Text] [Related]
17. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
[TBL] [Abstract][Full Text] [Related]
18. Thyroid Nodule Size at Ultrasound as a Predictor of Malignancy and Final Pathologic Size.
Cavallo A; Johnson DN; White MG; Siddiqui S; Antic T; Mathew M; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2017 May; 27(5):641-650. PubMed ID: 28052718
[TBL] [Abstract][Full Text] [Related]
19. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
Batawil N; Alkordy T
Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative frozen section can be reduced in thyroid nodules classified as Bethesda categories V and VI.
Huang J; Luo J; Chen J; Sun Y; Zhang C; Xu K; Ye Q; Huang P
Sci Rep; 2017 Jul; 7(1):5244. PubMed ID: 28701706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]